HEALTHCARE COSTS

Is high-cost U.S. cancer care worth ‘value of hope’ for patients?

A cluster of recently published articles might help policy-makers, patients, and providers decide when a high-cost treatment is “worth” the expense in terms of delivering better health to patients. » More

More drugs available in 2011, but spending on prescriptions leveled off

Last year, prescription drug spending leveled off, with seniors spending less on prescription drugs, and young people between the ages of 19 and 25 years spent more as they were able to stay on their parents’ health insurance, according to a new report from the IMS Institute for Healthcare Informatics. » More

CONTINUING EDUCATION

The impact of electronic health records on pharmacy practice

E-prescribing, a paperless, real-time transmission of data, places pharmacists squarely within the healthcare technology team.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.

HEALTHCARE REFORM

Officials say ACA helping government get tough on Medicare fraud

Two top officials of the Obama administration declared a high-tech war on Medicare fraud at a regional summit in Chicago on the Affordable Care Act. » More

FDA ACTIONS

FDA approves treatment for Parkinson’s, RLS

FDA approved rotigotine transdermal system (Neupro, UCB) for the treatment of the signs and symptoms of advanced stage idiopathic Parkinson’s disease and as a treatment for moderate-to-severe primary restless legs syndrome. » More

Counterfeit version of bevacizumab product contains no active ingredient

Lab tests recently conducted by FDA confirm that a counterfeit version of bevacizumab (Altuzan, Roche), an injectable cancer medication, contains no active ingredient, according to an FDA statement. » More

Label changes for diabetes products approved

FDA approved 2 label changes to Novo Nordisk’s liraglutide [rDNA] injection (Victoza) and its basal insulin analog (Levemir) last week. » More

CHAINS & BUSINESS

Pharmacy Development Services webinar will discuss management skills

The second in a series of webinars from Pharmacy Development Services will be available tonight (Tuesday, April 10) at 8 p.m.: What Every Pharmacy Owner Needs to Know about Management. » More

Survey

Does your employer allow the use of your doctor degree on your name tag?

a) Yes, my employer allows PharmD after my name or the use of the title Dr. before my name.
b) Yes, my employer allows PharmD after my name but not the title Dr. before my name.

c) No, my employer does not allow any doctor title before or after my name.

Respond here and see what your colleagues think, too.

Want to see the results of our last survey about whether pharmacists should have the authority to prescribe medications? Click here.

Voices

Digital Edition